Back to mobile site
Get it on Google Play

BAUSCH + LOMB receives FDA clearance for vitrectomy cutter

April 8, 2026 7:00 AM EDT Send to a Friend
Bausch + Lomb Corporation (NYSE/TSX: BLCO) announced that the U.S. Food and Drug Administration granted 510(k) clearance for its Bi-Blade+ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login